Hillsdale Investment Management Inc. Makes New Investment in Viemed Healthcare, Inc. $VMD

Hillsdale Investment Management Inc. bought a new position in shares of Viemed Healthcare, Inc. (NASDAQ:VMD) in the 1st quarter, HoldingsChannel.com reports. The institutional investor bought 199,109 shares of the company’s stock, valued at approximately $1,834,000.

A number of other large investors have also recently made changes to their positions in the stock. Wasatch Advisors LP grew its holdings in shares of Viemed Healthcare by 18.4% in the second quarter. Wasatch Advisors LP now owns 1,546,010 shares of the company’s stock worth $10,683,000 after purchasing an additional 240,346 shares during the last quarter. Two Sigma Investments LP lifted its holdings in Viemed Healthcare by 193.7% during the 3rd quarter. Two Sigma Investments LP now owns 251,410 shares of the company’s stock valued at $1,707,000 after buying an additional 165,797 shares in the last quarter. Rothschild Wealth LLC purchased a new stake in Viemed Healthcare in the 4th quarter valued at about $967,000. Arrowstreet Capital Limited Partnership grew its stake in Viemed Healthcare by 50.7% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 352,323 shares of the company’s stock worth $2,392,000 after acquiring an additional 118,589 shares in the last quarter. Finally, North Star Investment Management Corp. bought a new position in Viemed Healthcare in the 1st quarter worth about $921,000. 74.24% of the stock is owned by hedge funds and other institutional investors.

Viemed Healthcare Stock Performance

Shares of NASDAQ:VMD opened at $11.88 on Thursday. The firm’s 50 day simple moving average is $10.53 and its 200-day simple moving average is $9.28. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.10 and a current ratio of 1.22. Viemed Healthcare, Inc. has a one year low of $5.93 and a one year high of $12.61. The firm has a market cap of $455.44 million, a PE ratio of 32.11 and a beta of 1.10.

Viemed Healthcare (NASDAQ:VMD) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $0.06 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.03). Viemed Healthcare had a net margin of 5.20% and a return on equity of 10.52%. The firm had revenue of $75.41 million during the quarter, compared to analysts’ expectations of $74.40 million. As a group, equities analysts predict that Viemed Healthcare, Inc. will post 0.44 EPS for the current year.

Insiders Place Their Bets

In other news, insider William Frazier sold 10,000 shares of the stock in a transaction on Thursday, June 25th. The stock was sold at an average price of $11.72, for a total transaction of $117,200.00. Following the transaction, the insider owned 73,214 shares of the company’s stock, valued at approximately $858,068.08. This represents a 12.02% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Timothy Smokoff sold 20,000 shares of the firm’s stock in a transaction on Wednesday, June 24th. The shares were sold at an average price of $11.50, for a total value of $230,000.00. Following the transaction, the director owned 75,518 shares in the company, valued at approximately $868,457. This represents a 20.94% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 20.60% of the company’s stock.

About Viemed Healthcare

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.